Actavis Shutters Unit Following Watson Takeover R&D Double-Up
Following an analysis of its global R&D business Actavis says it will close its Maltese R&D unit at a cost of 60 jobs.
Archives for March 14, 2013
Shire Snaps Up Swedish Infant Blindness Drug Developer
Shire has entered the neonatology market by acquiring Premacure and a new therapy and delivery technology designed to treat infant blindness.